Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof
Patent Number 12128141 - October 29, 2024
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein…
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
Patent Number 12064521 - August 20, 2024
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein…
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
Patent Number 11666538 - June 6, 2023
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein…
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
Patent Number 11622941 - April 11, 2023
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein…
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
Patent Number 10987313 - April 27, 2021
The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising…
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
Application Number 20240350417 - October 24, 2024
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein…
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
Application Number 20230301923 - September 28, 2023
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein…
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
Application Number 20230092422 - March 23, 2023
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein…
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
Application Number 20210338591 - November 4, 2021
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein…
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
Application Number 20210128480 - May 6, 2021
The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising…
IMPAX LABORATORIES, LLC v. DR. REDDY'S LABORATORIES, LTD. et al
New Jersey District Court - July 18, 2024
IMPAX LABORATORIES, LLC v. DR. REDDY'S LABORATORIES, LTD. et al
New Jersey District Court - July 18, 2024
IMPAX LABORATORIES, LLC v. ASCENT PHARMACEUTICALS INC.
New Jersey District Court - April 18, 2024
IMPAX LABORATORIES, LLC v. ASCENT PHARMACEUTICALS INC.
New Jersey District Court - April 18, 2024
New York Hotel Trades Council, et al v. IMPAX LABORATORIES, INC., et al
U.S. Court of Appeals, Ninth Circuit - September 5, 2019
Fleming v. Impax Laboratories Inc. et al
California Northern District Court - November 22, 2021
ORDER by Judge Haywood S. Gilliam, Jr. GRANTING 110 PRELIMINARY APPROVAL OF SETTLEMENT.(ndr, COURT STAFF) (Filed on 11/22/2021)
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al
New Jersey District Court - March 23, 2020
OPINION and ORDER denying 196 Defendants' Motion in Limine; denying 198 Plaintiff's Motion in Limine. etc. Signed by Judge…
Fleming v. Impax Laboratories Inc. et al
California Northern District Court - May 21, 2019
ORDER by Judge Haywood S. Gilliam, Jr. Granting 81 Administrative Motion for Permission to File a Statement of Recent Decision. (ndrS,…
IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al
New Jersey District Court - April 18, 2018
AMENDED OPINION/ORDER that Actavis motion for summary judgment of noninfringement (Docket Entry No. 142), pursuant to Federal Rule of Civil…
Family Medicine Pharmacy, LLC v. Impax Laboratories, Inc.
Alabama Southern District Court - March 6, 2018
Final Judgment and Order Approving Class Settlement, as set out. This action is dismissed with prejudice. Signed by District Judge William H.…
Impax Laboratories, Inc. v. Federal Trade Commission
United States US Court of Appeals, Fifth Circuit - April 13, 2021
NEW YORK HOTEL TRADES COUNCIL V. IMPAX LABORATORIES, INC.
United States US Court of Appeals, Ninth Circuit - January 11, 2021
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al
New Jersey New Jersey District Court - March 23, 2020
OPINION and ORDER denying 196 Defendants' Motion in Limine; denying 198 Plaintiff's Motion in Limine. etc. Signed by Judge Stanley…
Williams v. Impax Laboratories, Inc.,
California Court of Appeal - November 8, 2019
IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al
New Jersey New Jersey District Court - July 25, 2019
OPINION AND ORDER; The Court concludes that Plaintiff is correct and that the phrase, "a controlled release oral solid formulation of…
Impax Laboratories, Inc. v. Federal Trade Commission
US Court of Appeals for the Fifth Circuit - April 13, 2021
NEW YORK HOTEL TRADES COUNCIL V. IMPAX LABORATORIES, INC.
US Court of Appeals for the Ninth Circuit - January 11, 2021
IMPAX LABORATORIES INC. v. LANNETT HOLDINGS INC.
US Court of Appeals for the Federal Circuit - July 2, 2018
IMPAX LABORATORIES INC. v. LANNETT HOLDINGS INC.
US Court of Appeals for the Federal Circuit - June 28, 2018
